BOSTON, Mass., May 31, 2012 – OvaScience™, a fertility company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of OvaScience, will present at the Jefferies 2012 Global Healthcare Conference in New York City on Thursday, June 7, 2012, at 10:30 a.m.
About OvaScience
OvaScience is a fertility company focused on the discovery, development and commercialization of new treatments for infertility. OvaScience is working to improve the treatment of female infertility based on patented technology exclusively licensed from Massachusetts General Hospital. The company’s team of scientists, physicians and advisers includes recognized leaders in the field of reproductive medicine.